{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T01:34:03Z","timestamp":1771378443490,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T00:00:00Z","timestamp":1480636800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s12185-016-2160-6","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T04:06:42Z","timestamp":1480651602000},"page":"692-696","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["5q\u2212 syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10)"],"prefix":"10.1007","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5034-3699","authenticated-orcid":false,"given":"Hiroshi","family":"Ureshino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruna","family":"Kizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Kusaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiko","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsujiro","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takero","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Ando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,2]]},"reference":[{"key":"2160_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.leukres.2008.08.015","volume":"33","author":"K Yamamoto","year":"2009","unstructured":"Yamamoto K, Okamura A, Katayama Y, Shimoyama M, Matsui T. Unbalanced whole-arm translocation der(5;19)(p10;q10) is a novel and recurrent cytogenetic aberration in myelodysplastic syndrome. Leuk Res. 2009;33:377\u201383.","journal-title":"Leuk Res"},{"key":"2160_CR2","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1111\/ajco.12051","volume":"10","author":"M Manabe","year":"2014","unstructured":"Manabe M, Takakuwa T, Nakano H, Harada N, Okamoto S, Aoyama Y, et al. Derivative (5;19)(p10;q10): a rare but recurrent whole-arm translocation in acute myeloid leukemia. Asia Pac J Clin Oncol. 2014;10:e122\u20136.","journal-title":"Asia Pac J Clin Oncol"},{"key":"2160_CR3","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1016\/j.leukres.2009.08.033","volume":"34","author":"K Yamamoto","year":"2010","unstructured":"Yamamoto K, Wakahashi K, Okamura A, Katayama Y, Shimoyama M, Matsui T. Two further cases of myelodysplastic syndrome and acute myeloid leukemia with der(5;19)(p10;q10): association with abnormalities involving chromosomes 12 and 21. Leuk Res. 2010;34:e38\u201341.","journal-title":"Leuk Res"},{"key":"2160_CR4","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1111\/j.1525-1438.2007.01185.x","volume":"18","author":"S Yeasmin","year":"2008","unstructured":"Yeasmin S, Nakayama K, Ishibashi M, Oride A, Katagiri A, Purwana IN, et al. Therapy-related myelodysplasia and acute myeloid leukemia following paclitaxel- and carboplatin-based chemotherapy in an ovarian cancer patient: a case report and literature review. Int J Gynecol Cancer. 2008;18:1371\u20136.","journal-title":"Int J Gynecol Cancer"},{"key":"2160_CR5","doi-asserted-by":"publisher","first-page":"4841","DOI":"10.1182\/blood-2007-08-078139","volume":"111","author":"SD Nimer","year":"2008","unstructured":"Nimer SD. Myelodysplastic syndromes. Blood. 2008;111:4841\u201351.","journal-title":"Blood"},{"key":"2160_CR6","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","volume":"120","author":"PL Greenberg","year":"2012","unstructured":"Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sol\u00e9 F, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120:2454\u201365.","journal-title":"Blood"},{"key":"2160_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1006\/geno.1996.0635","volume":"38","author":"P Finelli","year":"1996","unstructured":"Finelli P, Antonacci R, Marzella R, Lonoce A, Archidiacono N, Rocchi M. Structural organization of multiple alphoid subsets coexisting on human chromosomes 1, 4, 5, 7, 9, 15, 18, and 19. Genomics. 1996;38:325\u201330.","journal-title":"Genomics"},{"key":"2160_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1471-2164-11-195","volume":"11","author":"N Pironon","year":"2010","unstructured":"Pironon N, Puechberty J, Roiz\u00e8s G. Molecular and evolutionary characteristics of the fraction of human alpha satellite DNA associated with CENP-A at the centromeres of chromosomes 1, 5, 19, and 21. BMC Genom. 2010;11:195.","journal-title":"BMC Genom"},{"key":"2160_CR9","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1182\/blood-2010-04-273771","volume":"116","author":"J Boultwood","year":"2010","unstructured":"Boultwood J, Pellagatti A, McKenzie ANJ, Wainscoat JS. Advances in the 5q\u2212 syndrome. Blood. 2010;116:5803\u201311.","journal-title":"Blood"},{"key":"2160_CR10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/leu.2015.158","volume":"30","author":"U Oelschlaegel","year":"2016","unstructured":"Oelschlaegel U, Alexander R\u00f6hnert M, Mohr B, Sockel K, Herold S, Ehninger G, et al. Clonal architecture of del(5q) myelodysplastic syndromes: aberrant CD5 or CD7 expression within the myeloid progenitor compartment defines a subset with high clonal burden. Leukemia. 2016;30:517\u201320.","journal-title":"Leukemia"},{"key":"2160_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3324\/haematol.2010.038281","volume":"96","author":"M J\u00e4dersten","year":"2011","unstructured":"J\u00e4dersten M, Karsan A. Clonal evolution in myelodysplastic syndromes with isolated del(5q): the importance of genetic monitoring. Haematologica. 2011;96:177\u201380.","journal-title":"Haematologica"},{"key":"2160_CR12","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature10738","volume":"481","author":"L Ding","year":"2012","unstructured":"Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS, et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 2012;481:506\u201310.","journal-title":"Nature"},{"key":"2160_CR13","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/sj.leu.2401711","volume":"14","author":"G Rossi","year":"2000","unstructured":"Rossi G, Pelizzari AM, Bellotti D, Tonelli M, Barlati S. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients. Leukemia. 2000;14:636\u201341.","journal-title":"Leukemia"},{"key":"2160_CR14","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/sj.leu.2401067","volume":"12","author":"A Venditti","year":"1998","unstructured":"Venditti A, Del Poeta G, Buccisano F, Tamburini A, Cox-Froncillo MC, Aronica G, et al. Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia. Leukemia. 1998;12:1056\u201363.","journal-title":"Leukemia"},{"key":"2160_CR15","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1053\/j.seminoncol.2013.09.013","volume":"40","author":"S Bhatia","year":"2013","unstructured":"Bhatia S. Therapy-related myelodysplasia and acute myeloid leukemia. Semin Oncol. 2013;40:666\u201375.","journal-title":"Semin Oncol"},{"key":"2160_CR16","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1182\/blood-2013-07-512657","volume":"123","author":"DA Eichenauer","year":"2014","unstructured":"Eichenauer DA, Thielen I, Haverkamp H, Franklin J, Behringer K, Halbsguth T, et al. Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group. Blood. 2014;123:1658\u201364.","journal-title":"Blood"},{"key":"2160_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJM199902043400504","volume":"340","author":"LB Travis","year":"1999","unstructured":"Travis LB, Holowaty EJ, Bergfeldt K, Lynch CF, Kohler BA, Wiklund T, et al. Risk of leukemia after platinum-based chemotherapy for ovarian cancer. N Engl J Med. 1999;340:351\u20137.","journal-title":"N Engl J Med"},{"key":"2160_CR18","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.leukres.2008.07.006","volume":"33","author":"C Satoh","year":"2009","unstructured":"Satoh C, Tamura H, Yamashita T, Tsuji T, Dan K, Ogata K. Aggressive characteristics of myeloblasts expressing CD7 in myelodysplastic syndromes. Leuk Res. 2009;33:326\u201331.","journal-title":"Leuk Res"},{"key":"2160_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1470-2045(09)70003-8","volume":"10","author":"P Fenaux","year":"2009","unstructured":"Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, et al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol. 2009;10:223\u201332.","journal-title":"Lancet Oncol."},{"key":"2160_CR20","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1200\/JCO.2010.30.9245","volume":"29","author":"M Lubbert","year":"2011","unstructured":"Lubbert M, Suciu S, Baila L, Ruter BH, Platzbecker U, Giagounidis A, et al. Low-dose decitabine versus best supportive care in elderly patients with intermediate- or high-risk myelodysplastic syndrome (MDS) ineligible for intensive chemotherapy: final results of the randomized phase III study of the European Organisation for Rese. J Clin Oncol. 2011;29:1987\u201396.","journal-title":"J Clin Oncol"},{"key":"2160_CR21","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1056\/NEJMoa061292","volume":"355","author":"A List","year":"2006","unstructured":"List A, Dewald G, Bennett J, Giagounidis A, Raza A, Feldman E, et al. Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion. N Engl J Med. 2006;355:1456\u201365.","journal-title":"N Engl J Med"},{"key":"2160_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1182\/blood-2015-01-621664","volume":"126","author":"H Dombret","year":"2015","unstructured":"Dombret H, Seymour JF, Butrym A, Wierzbowska A, Selleslag D, Jang JH, et al. International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with\u00a0>30% blasts. Blood. 2015;126:291\u20139.","journal-title":"Blood"},{"key":"2160_CR23","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1200\/JCO.2015.66.0118","volume":"34","author":"V Santini","year":"2016","unstructured":"Santini V, Almeida A, Giagounidis A, Gropper S, Jonasova A, Vey N, et al. Randomized phase III study of lenalidomide versus placebo in RBC transfusion-dependent patients with lower-risk Non-del(5q) myelodysplastic syndromes and ineligible for or refractory to erythropoiesis-stimulating agents. J Clin Oncol. 2016;34:2988\u201396.","journal-title":"J Clin Oncol"},{"key":"2160_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12185-011-0987-4","volume":"95","author":"MC Ornstein","year":"2012","unstructured":"Ornstein MC, Sekeres MA. Combination strategies in myelodysplastic syndromes. Int J Hematol. 2012;95:26\u201333.","journal-title":"Int J Hematol"},{"key":"2160_CR25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s12185-010-0640-7","volume":"92","author":"H Yokoyama","year":"2010","unstructured":"Yokoyama H, Mori S, Kobayashi Y, Kurosawa S, Saito B, Fuji S, et al. Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia: a single-center analysis of 47 patients. Int J Hematol. 2010;92:334\u201341.","journal-title":"Int J Hematol"},{"key":"2160_CR26","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/sj.leu.2404774","volume":"21","author":"HK Al-Ali","year":"2007","unstructured":"Al-Ali HK, Brand R, van Biezen A, Finke J, Boogaerts M, Fauser AA, et al. A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Leukemia. 2007;21:1945\u201351.","journal-title":"Leukemia"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-016-2160-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-016-2160-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-016-2160-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T04:22:42Z","timestamp":1492662162000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-016-2160-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,2]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["2160"],"URL":"https:\/\/doi.org\/10.1007\/s12185-016-2160-6","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,2]]}}}